TAVR

Transcatheter aortic valve replacement (TAVR) is a key structural heart procedure that has rapidly expanded in the decade since it was first FDA cleared. TAVR has come a paradigm shift in how many aortic stenosis patients are treated, now making up more than 50% of U.S. aortic valve replacements. It is less invasive than open heart surgery and recovery times are greatly reduced. TAVR can also be used in patients who otherwise are too high risk to undergo surgery. TAVR is referred to as transcatheter aortic valve implantation (TAVI) in many placed outside of the U.S. TAVR inspired the growing areas of transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

RSS icon
Thumbnail

TAVR safe for patients with inflammatory bowel disease

Patients with Crohn’s disease and ulcerative colitis can safely undergo TAVR, researchers at the Cleveland Clinic have confirmed in a new analysis.

Permanent pacemaker implantation before or after TAVR linked to worse outcomes

Researchers tracked more than 49,000 TAVR patients, sharing their findings in Heart Rhythm. 

Thumbnail

Florida hospital celebrates 100th TAVR procedure

The procedure, like the hospital's first 99 TAVR cases, was a success. 

Thumbnail

Valve-in-valve TAVR outcomes ‘excellent’ after one year

Moderate to severe aortic regurgitation was seen in 0.9% of patients after 30 days and 1.3% after one year.

Tai chi could help ease depression, anxiety among stroke survivors

An eight-week tai chi course provided key benefits for older stroke survivors, researchers reported. 

How predilation affects TAVR outcomes for low-risk patients

The new study, published in Circulation: Cardiovascular Interventions, included data from nearly 500 TAVR patients.

Thumbnail

To delay or not to delay? When treating TAVR patients during the pandemic, heart teams faced big decisions

Delaying TAVR for six months can have a negative effect on patient outcomes. During the pandemic, however, there were certain times when a delay was safer than completing the procedure. 

Thumbnail

Presenting with additional chronic conditions can make a big impact on TAVR outcomes

Hypertension, for instance, can increase an individual's risk of post-TAVR hospitalization or mortality, according to a new analysis of more than 350 high-risk patients.  

Displaying 393 - 400 of 471

Around the web

Radiology Business
The impact of Trump tariffs on iodine contrast media costs

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.